Numerous groups are attempting to diversify COVID vaccine research
With communities of color historically underrepresented in clinical trials, numerous groups are working to diversify COVID-19 vaccine research.
With communities of color historically underrepresented in clinical trials, numerous groups are working to diversify COVID-19 vaccine research.
Novavax began late-stage trial of COVID-19 vaccine; Pharmacies prepare for increased flu shot demand; The inaugural MM+M 40 Under 40 event is September 29.
The goal for SurvivorNet going forward is to develop new products and content for cancer patients and doctors, Fairhead said.
Plus people moves at Omnicom and Astellas.
U.S. health officials testify before Congress; J&J begins late-stage vaccine trial; AstraZeneca’s COVID-19 vaccine trial remains under investigation by FDA.
FCB has partnered with Sermo, Haymarket Media Group and the National Suicide Prevention Lifeline.
The agency sent warning letters to vape companies selling e-cigarettes without premarket authorization.
FDA to issue guidance outlining tougher standards for a COVID-19 vaccine; Biden campaign balances criticizing Trump’s vaccine efforts with encouraging trust in vaccines; U.S. surpasses 200,000 deaths from coronavirus.
CDC reverses stance on airborne transmission of COVID-19; Group of Black doctors to independently vet COVID-19 decisions; Join the virtual MM+M Hall of Femme today.
The Blood Equality campaign, created by GMHC and FCB Health New York, advocates to reverse the ban on gay and bisexual men donating blood.